Orion Oyj (OTCMKTS:ORINY – Get Free Report) shares were up 2% during trading on Wednesday . The company traded as high as $26.63 and last traded at $26.63. Approximately 155 shares traded hands during mid-day trading, a decline of 97% from the average daily volume of 5,747 shares. The stock had previously closed at $26.10.
Orion Oyj Price Performance
The company has a 50 day moving average of $23.83 and a 200 day moving average of $24.63. The company has a current ratio of 2.42, a quick ratio of 1.41 and a debt-to-equity ratio of 0.25. The firm has a market cap of $7.44 billion, a price-to-earnings ratio of 20.91 and a beta of 0.24.
Orion Oyj Company Profile
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson’s disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.
Featured Stories
- Five stocks we like better than Orion Oyj
- Consumer Discretionary Stocks Explained
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- What is Forex and How Does it Work?
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Orion Oyj Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion Oyj and related companies with MarketBeat.com's FREE daily email newsletter.
